Furthermore, higher ERO1α levels were significantly associated with a higher presence of metastasis (Fig. 2c), suggesting that ERO1α upregulation may have contributed to HCC progression by promoting tumor metastasis. This evidence concerns the gene ERO1A and hepatocellular carcinoma.